Metraipolis › archive › dc_45c64a5b02da

Phenotypic impacts of treatment-selected mutations in HIV-2 protease on darunavir and lopinavir susceptibility: Evaluating genotypic HIV-2 drug resistance tools — Europe PMC PMID:41637462

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41637462
DOI
10.1371/journal.pgph.0005743
License (as archived)
solo-consultazione
Archived
2026-11-06T03:03:13.809Z
SHA-256 of the archived text
35f515cb85a32d0bd5682bb3786fcae14d63fc936f52b7ae4149efe3a15fcc62
Stable URL of this page
https://metraipolis.com/documento/dc_45c64a5b02da

How to cite

Phenotypic impacts of treatment-selected mutations in HIV-2 protease on darunavir and lopinavir susceptibility: Evaluating genotypic HIV-2 drug resistance tools — Europe PMC PMID:41637462 — Europe PMC (en), https://europepmc.org/article/MED/41637462 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_45c64a5b02da (Metraipolis archive dc_45c64a5b02da, sha256 35f515cb85a32d0bd5682bb3786fcae14d63fc936f52b7ae4149efe3a15fcc62)
BibTeX
@misc{dc45c64a5b02da,
  title = {Phenotypic impacts of treatment-selected mutations in HIV-2 protease on darunavir and lopinavir susceptibility: Evaluating genotypic HIV-2 drug resistance tools — Europe PMC PMID:41637462},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41637462},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_45c64a5b02da; sha256 35f515cb85a32d0bd5682bb3786fcae14d63fc936f52b7ae4149efe3a15fcc62},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41637462. Agents can read the archived copy with the MCP tool read_document.